Entropy Technologies LP Makes New $3.46 Million Investment in Xylem Inc. $XYL

Entropy Technologies LP bought a new position in Xylem Inc. (NYSE:XYL) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 25,373 shares of the industrial products company’s stock, valued at approximately $3,455,000.

A number of other institutional investors have also recently added to or reduced their stakes in XYL. AQR Capital Management LLC lifted its position in shares of Xylem by 14.4% during the 1st quarter. AQR Capital Management LLC now owns 30,955 shares of the industrial products company’s stock valued at $3,645,000 after acquiring an additional 3,900 shares during the last quarter. NewEdge Advisors LLC lifted its position in shares of Xylem by 3.3% during the 1st quarter. NewEdge Advisors LLC now owns 4,151 shares of the industrial products company’s stock valued at $496,000 after acquiring an additional 132 shares during the last quarter. Empowered Funds LLC lifted its position in shares of Xylem by 56.1% during the 1st quarter. Empowered Funds LLC now owns 8,678 shares of the industrial products company’s stock valued at $1,037,000 after acquiring an additional 3,120 shares during the last quarter. Arrowstreet Capital Limited Partnership lifted its position in shares of Xylem by 97.6% during the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 11,151 shares of the industrial products company’s stock valued at $1,442,000 after acquiring an additional 5,509 shares during the last quarter. Finally, EverSource Wealth Advisors LLC lifted its position in shares of Xylem by 114.0% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,192 shares of the industrial products company’s stock valued at $154,000 after acquiring an additional 635 shares during the last quarter. 87.96% of the stock is currently owned by institutional investors and hedge funds.

Xylem Trading Down 0.1%

NYSE XYL opened at $109.92 on Monday. Xylem Inc. has a 1-year low of $105.29 and a 1-year high of $154.27. The company has a current ratio of 1.46, a quick ratio of 1.10 and a debt-to-equity ratio of 0.13. The company has a market capitalization of $26.13 billion, a PE ratio of 27.34, a price-to-earnings-growth ratio of 1.57 and a beta of 1.05. The firm’s fifty day simple moving average is $115.78 and its 200-day simple moving average is $127.25.

Xylem (NYSE:XYL) last posted its quarterly earnings results on Tuesday, April 28th. The industrial products company reported $1.12 earnings per share for the quarter, topping analysts’ consensus estimates of $1.09 by $0.03. Xylem had a net margin of 10.79% and a return on equity of 11.26%. The business had revenue of $2.13 billion for the quarter, compared to the consensus estimate of $2.11 billion. During the same period in the prior year, the business posted $1.03 earnings per share. Xylem’s revenue for the quarter was up 2.7% compared to the same quarter last year. Xylem has set its FY 2026 guidance at 5.350-5.600 EPS. As a group, sell-side analysts anticipate that Xylem Inc. will post 5.51 earnings per share for the current fiscal year.

Xylem Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, June 25th. Stockholders of record on Thursday, May 28th will be paid a $0.43 dividend. The ex-dividend date of this dividend is Thursday, May 28th. This represents a $1.72 dividend on an annualized basis and a dividend yield of 1.6%. Xylem’s dividend payout ratio is 42.79%.

Xylem declared that its board has authorized a share buyback program on Wednesday, February 25th that authorizes the company to repurchase $1.50 billion in outstanding shares. This repurchase authorization authorizes the industrial products company to purchase up to 4.8% of its shares through open market purchases. Shares repurchase programs are typically a sign that the company’s management believes its stock is undervalued.

Analyst Ratings Changes

A number of equities research analysts have recently commented on XYL shares. Oppenheimer cut their price objective on Xylem from $160.00 to $158.00 and set an “outperform” rating for the company in a research report on Wednesday, April 29th. TD Cowen restated a “hold” rating on shares of Xylem in a report on Monday, February 23rd. UBS Group increased their target price on Xylem from $132.00 to $133.00 and gave the company a “neutral” rating in a report on Wednesday, April 29th. Barclays reduced their target price on Xylem from $156.00 to $154.00 and set an “overweight” rating for the company in a report on Wednesday, April 29th. Finally, Citigroup reduced their target price on Xylem from $174.00 to $168.00 and set a “buy” rating for the company in a report on Wednesday, April 29th. Seven equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $152.77.

Insiders Place Their Bets

In other news, CAO Geri-Michelle Mcshane sold 4,269 shares of the company’s stock in a transaction on Thursday, May 7th. The shares were sold at an average price of $117.46, for a total value of $501,436.74. Following the transaction, the chief accounting officer directly owned 3,605 shares of the company’s stock, valued at approximately $423,443.30. This represents a 54.22% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Jerome A. Peribere purchased 1,210 shares of the company’s stock in a transaction dated Monday, May 4th. The stock was bought at an average cost of $116.61 per share, for a total transaction of $141,098.10. Following the completion of the purchase, the director directly owned 27,209 shares of the company’s stock, valued at $3,172,841.49. The trade was a 4.65% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Corporate insiders own 0.32% of the company’s stock.

Xylem Company Profile

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.